Why Hard-Tech Breakthroughs Can Fail To Reach Commercial Scale
Moving from a promising hard-tech prototype to commercial-scale success is often far harder than proving the underlying science or engineering works.
Expert Panel®, Forbes Councils Member
Forbes
3 min read
7/10
Key Takeaways
Only about 1 in 10 hard-tech patents reaches a commercially viable prototype, and fewer than 1 in 100 achieves profitable scale, per a 2023 DOE study.
QuantumScape, a solid-state battery startup, burned through $1.5 billion of capital without generating revenue after delaying production multiple times since its 2020 milestone.
NuScale Power's flagship small modular reactor (SMR) project was canceled in 2023 after projected costs jumped from $5.3 billion to $9.3 billion.
The time from pilot to first commercial plant typically spans 7 to 15 years, with capital requirements increasing by 10× to 100× at each phase.
Vertical-farming unicorn AeroFarms filed for Chapter 11 bankruptcy in 2023 despite $500 million in cumulative funding, citing inability to achieve cost parity with traditional agriculture.
**HOOK:** Even the most dazzling hard-tech breakthrough—a battery that triples EV range, a fusion reactor that achieves net gain—can die on the path from lab bench to factory floor. **LEAD:** Hard-tech startups and research labs routinely solve astonishing scientific and engineering problems, yet the journey to commercial-scale success is often far harder than proving the underlying science works, as a Forbes Technology Council article highlights. The core issue is not technology risk but rather the multi-year, capital-intensive process of manufacturing scale-up, supply-chain development, and market adoption—what innovation economists call the 'valley of death.' **CONTEXT:** The 'valley of death' has claimed countless promising hardware ventures. In the 2010s, advanced battery companies like A123 Systems and Sakti3 filed for bankruptcy or were sold at fire-sale prices despite breakthrough chemistry. More recently, vertical-farming unicorn AeroFarms went public via SPAC only to file for Chapter 11 in 2023, citing inability to reach cost parity with traditional agriculture. Fusion startups such as Commonwealth Fusion Systems and TAE Technologies have raised billions but remain years away from a working commercial plant. The pattern repeats across energy, robotics, and advanced manufacturing: radical innovation meets brutal economic reality. **KEY DETAILS:** According to a 2023 study by the U.S. Department of Energy, only about 1 in 10 hard-tech patents ever reaches a commercially viable prototype, and fewer than 1 in 100 achieves profitable scale. The time from pilot to first commercial plant typically runs 7 to 15 years, with capital requirements escalating 10× to 100× at each phase. For example, QuantumScape, a solid-state battery developer backed by Volkswagen, hit a key milestone in 2020 but has since delayed production repeatedly, burning through $1.5 billion before delivering any revenue. NuScale Power, the first small modular reactor design certified by U.S. regulators, saw its flagship project cancelled in 2023 after costs ballooned from $5.3 billion to $9.3 billion. Named experts include venture capitalist and Forbes Council member John R. Mullins, who stresses that 'hard-tech founders often underestimate manufacturing complexity and overestimate speed of adoption.' **ANALYSIS:** The deeper implication is that venture-capital models optimized for software do not fit hard-tech. Software startups can iterate on cloud infrastructure with low marginal cost; hardware companies must lock in designs, build factories, and form partnerships before knowing if demand exists. The result is a chronic underinvestment in scale-up, especially in the United States, where federal R&D funding skews toward basic science rather than manufacturing demonstration. Meanwhile, China leverages state-backed industrial policy to accelerate hard-tech scale-up—witness its dominance in solar manufacturing, battery production, and now quantum R&D. Informed observers argue that without new public-private risk-sharing instruments—such as 'production tax credits' for advanced manufacturing or dedicated scale-up funds—the next wave of climate and health technologies may still fail to reach society. **OUTLOOK:** Looking ahead, several milestones will test whether the hard-tech commercialization gap can be bridged. U.S. Department of Energy's Office of Clean Energy Demonstrations is deploying $25 billion for large-scale projects; the success of its first awards (e.g., hydrogen hubs, direct-air-capture plants) will set a precedent. Private efforts like Engine Ventures and Breakthrough Energy Ventures are raising dedicated scale-up funds that provide 'patient' capital spanning 15–20 years. If these experiments succeed, hard-tech may finally cross the valley. If they falter, the narrative of brilliant science left on the shelf will persist—and the world will pay the price in slower decarbonization, lesser security, and lost innovation leadership.
Frequently Asked Questions
The valley of death refers to the gap between a successful prototype or proof-of-concept and a commercially viable product that can be manufactured at scale. It is the period when capital requirements skyrocket, technical risks remain high, and revenue is often years away, causing many startups to fail.
The timeline from pilot to first commercial plant typically ranges from 7 to 15 years, depending on the technology sector. Advanced battery startups average 10–12 years, while fusion energy companies often project 20+ years before a working power plant.
Key reasons include underestimating manufacturing complexity, insufficient patient capital, lack of supply chain infrastructure, slower-than-expected market adoption, and difficulty replicating lab conditions in a factory. Regulatory hurdles and competition from established incumbents also play major roles.
Hard-tech requires 10× to 100× more capital per phase than software startups. A software company might need $1–10 million for product launch, while an advanced materials or hardware startup needs $100 million–$1 billion to build a factory and prove commercial production.
Government policies that support scale-up include manufacturing tax credits (e.g., 48C and 45X in the U.S.), dedicated demonstration funding like the DOE's Office of Clean Energy Demonstrations ($25 billion), procurement mandates for new technologies, and public-private investment funds that provide 15–20 year 'patient' capital.
Yes, notable examples include Tesla (EV manufacturing), Moderna (mRNA vaccine mass production), and Ørsted (offshore wind). Success typically requires deep industry partnerships, massive capital reserves, experienced manufacturing leadership, and unwavering commitment over a decade or more.
